# OnCo record metro-plus-varanasi (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/metro-plus-varanasi/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "metro-plus-varanasi" ;
  schema:name "METRO PLUS (Tata Memorial Centre, Varanasi)"@en ;
  schema:description "Adding low-cost oral metronomic tablets to standard paclitaxel-carboplatin doubled median survival from 5 to 10 months in a randomised trial run in Varanasi."@en ;
  schema:url <https://onco.cc/trials/metro-plus-varanasi/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/GO-25-00721> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/>, <https://onco.cc/cancers/buccal-mucosa-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/methotrexate/> ;
  onco:institutions <https://onco.cc/institutions/homi-bhabha-cancer-hospital-varanasi/>, <https://onco.cc/institutions/tata-memorial/> ;
  onco:trials <https://onco.cc/trials/metronomic-vs-cisplatin-tmh/> ;
  onco:people <https://onco.cc/people/kapoor-akhil/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-generic-repurposing/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-kapoor-jco-glob-oncol/> .